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Abstract
The transcription factor Gli3 is acting mainly as a transcriptional repressor in the Sonic hedgehog signal transduction
pathway. Gli3 contains a repressor domain in its N-terminus from residue G106 to E236. In this study we have characterized
the intracellular structure of the Gli3 repressor domain using a combined bioinformatics and experimental approach.
According to our findings the Gli3 repressor domain while being intrinsically disordered contains predicted anchor sites for
partner interactions. The obvious interaction partners to test were Ski and DNA; however, with both of these the structure of
Gli3 repressor domain remained disordered. To locate residues important for the repressor function we mutated several
residues within the Gli3 repressor domain. Two of these, H141A and H157N, targeting predicted helical regions, significantly
decreased transcriptional repression and thus identify important functional parts of the domain.
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Introduction
The expression of human genes is controlled by numerous
transcription factors. Depending on the physiological context
genes are activated by transcriptional activators or repressed by
transcriptional repressors. During the development of organism,
the fine-tuning of gene expression depends on an intricate balance
between positive and negative regulators. There are three
transcription factors (Gli1, Gli2 and Gli3) in the Sonic hedgehog
signal transduction pathway [1]. In their central part these
proteins contain a conserved DNA binding domain (DBD)
consisting of five zinc-fingers. The structure of the DBD from
Gli1 has been solved by X-ray analysis [2]. Here, the zinc-fingers
3, 4 and 5 closely contact the DNA with fingers 4 and 5
determining the target DNA sequence (GACCACCCA) [3] of Gli
binding. The first finger does not contact DNA and the second
finger only partially interacts with DNA. All the three Gli proteins
contain a transcriptional activator domain (TAD) at their C-
terminus [4,5]. For transcriptional repression Gli proteins utilize at
least two mechanisms. The first one, common to all three Gli
proteins, is dependent on Sufu and histone deacetylase [6]. The
second one is histone deacetylase independent, involving the
domain that we previously identified and named the repressor
domain (RD) [7]. Here, we investigate the structure and partner
interactions of this domain. The RD is only present in the N-
terminus of Gli2 and Gli3 but not in Gli1 [4,7]. An alternative,
third mechanism of negative transcriptional regulation by Gli3 has
been suggested to involve Ski and histone deacetylation, indicating
a general mechanism for all Gli proteins [8]. In vivo, Gli3
transcriptional repression has been shown in Sufu knockout mice,
suggesting Sufu independent repression mechanism [9].
The proteins or protein domains involved in transcriptional
regulation often belong to the class of intrinsically disordered
proteins (IDP) or regions (IDR) [10,11]. Structural disorder
provides advantages in fulfilling the dynamic processes of gene
regulation and signal transduction, and is more frequent in
multicellular organisms, suggesting complex regulatory mecha-
nisms [12,13].
In some instances the IDR undergoes binding-coupled folding
and becomes functional [14], whereas in other cases a larger
degree of fuzziness in the complex is possible [15]. Hence, the
IDPs recognise and interact with their partners by a number of
mechanisms. A predominant one utilizes short sequence elements
displaying higher structural propensities in the disordered,
unbound state. These sequence elements are known as molecular
recognition features or MoRFs [16]. It has been reported that
many IDPs contain low-stability structural elements [17,18].
In this work we have studied the biophysical properties of the RD
of Gli3 as previously mapped to span residues G106 to E236 [7].
Our results indicate that it constitutes an intrinsically disordered
region. In addition, we have investigated its interactions with
various potential partners. Sufu is a known partner and negative
regulator of all Gli proteins, but the Gli3 interaction site for Sufu
(S333YGH337 [19]) does not overlap with the RD. Another partner
of Gli3, the Ski protein, has also been linked to the repression
PLOS ONE | www.plosone.org 1 October 2013 | Volume 8 | Issue 10 | e76972
function of Gli3 [8]. The interaction site for Ski has been mapped to
N-terminus of Gli3 (1–397). This site potentially overlaps with the
RD, thus making Ski a possible target for Gli3RD.
Some transcription factors bind DNA through their IDR [20].
Therefore, we investigated whether Gli3RD, as IDR, interacts
with DNA. The transcription factor p53 has two DNA-binding
domains: a disordered C-terminal domain (CTD) and a structured
core domain [21]. The CTD binds to DNA in a sequence-
independent manner and slides along DNA. This assists the core
domain in finding its consensus site. The DNA binding of RNA
polymerase II (RNA pol II) [22] is facilitated by its predominantly
disordered CTD [18]. This domain is proline rich and bears some
resemblance to the proline rich sequence of Gli3RD. The DNA
binding of RNA pol II CTD is not sequence specific but is
dependent on the intercalation of the aromatic ring of tyrosine into
the DNA strands [22]. There are eight tyrosine residues in the
Gli3RD sequence and some of them have the same spacing
between tyrosine and proline as in the CTD of RNA pol II. This
suggests that if Gli3RD is binding DNA, it might also be sequence-
unspecific. It is known that Gli3 binds to its target genes through
the Zn-finger domain that recognises a specific DNA sequence-
the Gli consensus site. It has not been observed that Gli3 is able to
bind any other sequence in addition to its known DNA binding
sequence [23]. We reasoned that if the RD was able to bind DNA,
it should occur in a sequence-independent manner, otherwise an
additional consensus sequence for Gli3 should have been
described.
The Gli3RD contains several histidines. Histidines can coordi-
nate Zn2+ ions and according to Karlin [24] there are six classes of
histidine ligands. Within Gli3RD, positions H121/H157 and
H141/H147 resemble class II and I Zn2+-ligands, respectively. For
that reason we decided to test whether these histidines coordinate
Zn2+. We mutated these histidines and tested the repressor
function of the resultant variants.
A useful method for studying protein folding is in-cell NMR
where the spectrum is measured directly inside the living cells in
physiologically relevant conditions. Measurements are often
carried out by expressing the target protein in E.coli. We may
suppose that the E.coli intracellular environment is more native-
like even for an eukaryotic protein than the dilute solution
conditions. It is known that the conformation of IDPs may be
sensitive to molecular crowding of the environment [25,26,27].
Therefore it is appropriate to carry out the studies as in-cell NMR.
The 15N,1H-HSQC NMR spectrum of IDP has low dispersion of
signals in the 1H-dimension within a narrow region around
8 ppm. Certain residues give NMR signals which are easily
recognizable due to their distinct positioning. These are the cross-
peaks of glycines, the mirrored signal from the side chains of
asparagines and glutamines and the signal from the side chain of
arginines. The prolines are residues that do not give rise to a signal
in the NMR spectrum.
We have described here Gli3RD as an IDR. In regard to its
function as a transcriptional repressor we aimed to investigate
whether Gli3RD binds Ski or DNA. In addition, we also examined
the secondary structure induction of Gli3RD. In a functional
assay, H141 and H157 were identified as important functional
parts of the domain.
Results and Discussion
Gli3RD is predicted to have both order and disorder
features, with a mostly disordered N-terminal part
The transcription factor Gli3 contains an RD in its N-terminus
that represses gene expression. We previously identified the
Gli3RD to reside between residues G106 to E236 [7] as depicted
in Fig. 1A. Sequence analyses of Gli3RD revealed higher than
average content of histidines, serines and prolines, particularly in
the N-terminal region from residues G106 to D170. This makes
the sequence being potentially capable of binding to Zn2+ ions,
post-translationally modified, and extended and rigid. The
Gli3RD sequence appears to be mostly disordered when analysed
by disorder-predicting algorithm (VL XT, PONDR, [28]),
especially its C-terminal region (Fig. 1D, dashed line), while the
N-terminal part appears more ordered. The order-predicting
programme, Hierarchical Neural Network, HNN method [29],
(Fig. 1B, grey line) also reveals Gli3RD to be predominantly
disordered, containing several sequence stretches with higher
order probability, mostly within the C-terminal part of Gli3RD.
These potentially ordered elements are two short extended strands
from positions F173 to I176 and S214 to S217 (Fig. 1B, dashed
line) and one short a-helix at position N198 to L207 (Fig. 1B, black
line). One potentially extended strand stretching from residue
G106 to M111 (Fig. 1B, dashed line) was predicted in the N-
terminus of RD. The loss of probability of disorder around
position P178 (Fig. 1D, dashed line) coincides with the predicted
extended strand at positions F173 to I176 (Fig. 1B, dashed line).
The next minimum of disorder probability at position I197
(Fig. 1D, dashed line) corresponds to the predicted a-helix at
position N198 to L207 (Fig. 1B, black line). Using ANCHOR
programme [30] to predict protein binding sites prone to undergo
disorder-to-order transitions, we identified two sites in the C-
terminal region from residue D170 to I174 and residues P199-
T219 (Fig. 1D, black line). The first site (D170-I174) is close to the
predicted extended strand (F173-I176) while the second site (P199-
T219) overlaps with the sequence prone to form an a-helix (N198-
L207), (Fig. 1B and 1E). These sites can probably undergo
structuralisation upon binding to a functional partner, while
remaining disordered in a free state. When analysed by the
method of Uversky [31] that assesses intrinsic disorder based on
the ratio between mean hydrophobicity and mean net charge,
Gli3RD as a whole was predicted to be an ordered domain.
Accordingly, the hydrophobicity/charge balance does not support
strongly disordered regions, as the N-terminal part (residues106–
170) lies at the order/disorder boundary and C-terminal part
(residues171–236) is situated at the order site (Fig. 1C). The
hydrophobisity cluster analysis (HCA) performed with the
metaserver MeDor [32], (Fig. 1E) reveals the absence of
hydrophobic core which, combined with the high proline content
will contribute to the extended state of Gli3RD. The hydrophobic
residues within RD colocalise with proline residues to form
proline- and hydrophobic residues- rich sites connected by short
sequences depleted from these residues. While the proline rich sites
are rigid, the linkers seem to be more flexible. Based on the HCA,
(Fig. 1E) such linker sequences are D138-R145 and T159-S165.
One hydrophobic cluster is seen around position 200, correspond-
ing to the predicted a-helix (Fig. 1E).
It has been found that most of the proteins involved in
transcriptional regulation are either completely disordered or
contain large regions of intrinsic disorder [20]. Consistent with
this, Gli3 also contains extensive regions of intrinsic disorder. The
whole N-terminus up to the Zn-fingers (residues 1-480), including
RD (residues 106-236), shows high probability for disorder
(PONDR, HNN; data not shown). Taken together, we conclude
that the RD contains properties of both an ordered and disordered
protein, suggesting that folding-upon-binding may occur by
utilizing the two C-terminal anchor sites.
Gli3RD Is Intrinsically Disordered
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Gli3RD is intrinsically disordered in a native-like
environment as determined by in-cell NMR
To determine the structure of Gli3RD, this 15.575-kDa protein
domain was His-tagged and expressed in E. coli. The NMR
spectrum of Gli3RD expressing cells (Fig. 2A) is qualitatively
similar to that of the purified protein, measured at pH 7.4 (Fig. 2B).
All of the proton peaks lie within a narrow window of 8 ppm that
is typical for unfolded peptides. The E. coli control cells, not
expressing Gli3RD, are shown in Fig. 2C. At physiological pH we
detected half of the Gli3RD cross peaks (Fig. 2A) as opposed to the
spectrum of the purified protein at pH 5.8 (Fig. 2D). It is possible
that a folded fraction bound to a protein partner may have too
broad peaks to be seen in the NMR spectrum, or that the missing
peaks are not seen due to broadening caused by intra-molecular
interaction. However, since Gli3RD is expressed in a heterologous
system it most probably has no endogenous binding partner but
may interact with the intracellular components unspecifically [33].
The sequence of Gli3RD is proline rich, rendering its structure
more rigid and extended thereby making intra-molecular interac-
tions unlikely. Most probably the missing resonances are due to the
faster proton exchange occurring at higher pH [34].
In the NMR spectrum of purified Gli3RD we could recognise
all five glycines and the side chains of the three asparagines
(Fig. 2D), while the signals from the side chains of the seven
arginines were visible but overlapping (Fig. 2D). At physiological
pH two glycines are detectable (Fig.2B), and they are also visible in
the in-cell spectrum (Fig. 2A). This analysis provides supporting
evidence that the structure of Gli3RD is disordered in the
intracellular environment.
Gli3RD does not bind Ski
It is known that IDRs/IDPs can undergo binding-coupled
folding with their functional partners. For that reason we
attempted to induce Gli3RD folding using its potential partner
Ski, previously reported to interact with the N-terminal part of
Gli3 (residues 1–397) that contains the repressor domain (106–
236) [8]. To accomplish this, a Ski variant (residues G88 to Y291)
was expressed and purified as a maltose-binding (MBP) fusion
protein and then added to the 15N-labelled Gli3RD. The NMR
spectrum of Gli3RD remained unchanged in the presence of
MBP-Ski (data not shown) indicating no major structural changes
of Gli3RD in the presence of Ski. We then tested their interaction
by co-immunoprecipitation analysis using tagged over-expressed
Figure 1. Sequence analysis of human Gli3RD. (A) The relative position of RD within Gli3 from residues G106 to E236. (B) Gli3RD structure
prediction with the Hierarchical Neural Network prediction method. The probability for a-helix (a) formation is shown with (-), extended strand (—)
and random coil (-). (C) Net charge/hydrophobicity plot of the Gli3RD, as well as of the N- and C-terminus shown separately. The charge/
hydrophobicity diagram is divided into two regions by a line (-) corresponding to the equation (R) = 2,743(H)-1,109. Proteins on the left and right side
of the diagram are predicted to be disordered and ordered, respectively. (D) Prediction of disorder by PONDR (VL XT algorithm) is shown with a
dashed line (—) and the binding regions prediction by ANCHOR is indicated with a line (-). (E) The hydrophobisity cluster analysis combined with
secondary structure prediction and amino acid sequence of the human Gli3 repressor domain.
doi:10.1371/journal.pone.0076972.g001
Gli3RD Is Intrinsically Disordered
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proteins. However, we did not detect an interaction between
Gli3RD and Ski (data not shown). Ski utilizes HDACs to achieve
transcriptional repression, suggesting a general mechanism of
repression for all three Gli proteins. However, the identified RD
does not use HDACs to achieve repression and is found in Gli2
and Gli3 only, but not in Gli1 [7]. Probably the interaction site for
Ski is located more upstream from RD, possibly overlapping with
the Sufu-binding site (S333YGH337). Alternatively, Ski might
interact with Gli3 not directly but through Sufu.
Gli3RD does not bind DNA
It has been emphasised that structural disorder is widespread
among transcription factors and nucleic acids binding proteins
[10,11]. Thus, we subsequently investigated whether GLi3RD
interacts with DNA or otherwise. For this we used CD
spectroscopy, because this technique has been successfully
employed to study the binding of architectural proteins (HMGB1,
H1) to DNA [35]. To test if DNA could induce binding-coupled
folding of Gli3RD we obtained the CD spectrum of purified
recombinant Gli3RD alone or together with a 21 base-pair
scrambled sequence DNA oligonucleotide or plasmid DNA to
exclude DNA size requirements. After addition of oligonucleotide
or plasmid DNA at an stoichiometric ratio of 1:1, no dramatic
change in spectral appearance was observed, suggesting that
Gli3RD had remained disordered (data not shown). However,
although DNA did not induce binding-coupled structure in
Gli3RD (CD may not detect low-affinity binding), these two
molecules might still interact. We decided to test this possibility by
Electrophoretic Mobility Shift Assay (EMSA) and expressed the
Gli3RD in HEK293 cells as a Gal4DBD-tagged protein. The cell
lysate of HEK293 cells (Fig. 3, lane 2) or a Gli3RD-expressing cells
(Fig. 3, lane 3) was incubated with a 32P-labelled 21 base-pairs
scrambled DNA oligomers. If Gli3RD was able to bind the
labelled oligonucleotide a band corresponding to the DNA-
Gli3RD complex should appear. In Fig. 3, comparison of lanes 2
and 3 (with and without Gli3RD, respectively) revealed no
additional bands, implying that Gli3RD does not bind DNA. To
ascertain that Gli3RD was present in the cell lysate, we used
Figure 2. The 1H-15N HSQC NMR spectra. (A) in-cell spectrum of E.coli expressing Gli3RD, (B) Gli3RD in solution at pH 7.4, (C) in-cell spectrum of
uninduced E.coli and (D) Gli3RD in solution at pH 5.8. The cross-peaks from glycines (G), the mirrored cross-peaks from the side chains of asparagines
(N) and the signals from the side chain of arginines (R) are denoted in circles.
doi:10.1371/journal.pone.0076972.g002
Gli3RD Is Intrinsically Disordered
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labelled Gal4BS oligonucleotides binding to the Gal4DBD tag of
Gli3RD. The corresponding complex, comprising Gli3RD-
Gal4DBD protein / Gal4BS oligo is seen in Fig. 3, lane 5, as a
specific band. The specificity of this complex was proved by out-
competing with unlabelled Gal4BS oligonucleotide (Fig. 3, lane 7)
but not by scrambled oligo (Fig. 3, lane 6). We noticed that
Gli3RD did not alter the DNA binding of its tag, Gal4DBD.
Therefore, we exclude the mechanism where Gli3RD functions at
the DNA level, by preventing the Gli3 Zn-finger to bind to DNA.
The repression activity of Gli3RD is lost in H141A and
H157N mutants
Karlin and Zhu describe six classes of Zn-ligands [24]. The
positions of H121/H157 and of H141/H147 resemble classes II
and I, respectively, of Zn2+-binding ligands. We investigated
whether the repression function of Gli3RD is dependent on Zn2+-
binding. This was addressed in a functional assay by comparing
the activities of wild type to histidine-mutated Gli3RD variants.
For such mutational analysis we chose H121 and H157 since they
resemble the first and the third histidines from class II site of Zn2+-
binding ligands (H121xH and a third histidine157 distant in the
sequence) [24]. We also selected H141 and H147 because they
resemble the third and the second histidines from a class I site
(HExxH141xxGxxH147). Moreover, the two sites are also posi-
tioned in two sequence-stretches predicted by HNN to form low-
populated a-helices (and lower than the helix in the C-terminal
part). We mutated H121, H141, H147 and H157 to alanines
separately and in a double mutant H121/147A, where both classes
of Zn2+-ligands were expected to be affected. In addition, the
H157 was substituted for asparagines, since asparagine and
histidine have similar, but not identical, space requirements and
hydrogen bonding capabilities. However, asparagine is unable to
coordinate Zn2+-ions. Asparagine was also chosen because,
contrary to H157A, its substitution significantly alters the
predicted local helicity at that site which might be involved in
partner recognition. All proteins were expressed as tagged versions
from DNA in HEK293 cells. The constructs encoded Gal4 DBD-
fusion proteins and we measured their effect on transcriptional
activity of Gal4 binding site-containing luciferase reporter
(Fig. 4A).
The mutation of the first histidine (H121) from class II did not
affect the repression function. The second histidine mutation
(H147) from class I, also left the repression function unaltered. To
verify that repression is Zn2+-independent we combined the H121
and H147 mutations in a double mutant H121/147A. In this
mutant, both putative Zn2+-ligand classes were affected. Despite
targeting both classes I and II, the repression function remained
intact. The activity of the double mutant is slightly different but
falls within the range of other mutants (Fig. 4A).
Upon mutating the histidines H141 or H147 that resemble the
class I Zn-ligands, we observed a significant loss of repression
activity in the H141A only. Thus, it is possible that H141
participates in Zn2+ coordination together with a more distant
histidine. On the one hand, Gli3RD is a proline rich sequence,
making its structure extended and therefore any long-range
intramolecular interactions more difficult. On the other hand,
H141 is at the peak of a low-populated predicted a-helix that
reaches a minimum at H147 (Fig 4B). Since the H141A
significantly changes the structural ensemble of the above a-helix
and correspondingly affects the repressor function, we speculate
that it might constitute a protein interaction site or functionally
important region with distinct structural dynamics. In the case of
H157, the activity of the domain was preserved in H157A variant
whereas it was lost in H157N. By analogy with H141A, while the
H157N variant increases the predicted helicity by more than
300%, the same does not hold true for the functionally intact
H157A variant. Therefore we speculate that the change in the
structural ensemble of the predicted a-helix, may respectively
either impair or enhance partner recognition via altering a specific
MoRF [16]. This remains to be proven when the Gli3RD
interaction partner is known. The observed loss of activity in the
H141A and H157N variants points that these residues most
probably constitute important functional parts of the repressor
domain.
Our analyses were performed using the RD expressed alone
(fused to a 6xHis-tag) and not as part of the full-length Gli3 protein
or as a larger part encompassing the RD and the surrounding
region. It cannot be ruled out that in the composition of the entire
protein this domain has diminished spatial freedom due to
stabilizing inter-domain connections and is therefore more folded
than we observed [36]. However, homologous domains are
present in different proteins, meaning that the information about
their function and folding is mainly coded within the domain
sequence, and only to a minor extent by the surrounding context
of the protein. It cannot be ruled out that, although the domain
appears disordered on its own, it can undergo structural changes
upon interaction with a binding partner in the context of the full-
length protein only. Nevertheless, as the Gli3RD domain on its
own has repressor function (Fig. 4A; [7]), the latter is not likely.
In conclusion, we have described the Gli3RD as an intrinsically
disordered domain. The RD does not bind and fold in the
presence of neither Ski nor DNA. The H141A and H157N
mutants point to important functional parts of the repressor
domain, possibly involving a-helical MoRFs. The H157 shows
partial functional plasticity, tolerating its substitution for alanine
but not for aspargine.
The pursuit for binding partner and complex structure will
continue with this and other variants of the Gli3RD. An
interesting option would be to study the repressor complex
forming on the promoter region of one of the target genes of GLI
proteins, i.e. PTCH or GLI1, as well as the one forming with the
DBD itself.
Figure 3. Electrophoretic mobility shift analysis of Gli3RD and
DNA binding. Cell lysate from Gli3RD or mock-transfected HEK293
cells incubated with labelled scrambled sequence oligonucleotide is
shown in line 3 and line 2, respectively. As a negative control, the
labelled scrambled oligonucleotide was loaded alone, without a cell
lysate, on line 1. Labelled Gal4 binding site (BS) oligonucleotides were
used to confirm the presence of Gal4 DBD tagged Gli3RD. On line 4 the
Gal4 BS oligonucleotide is loaded alone. The DNA-protein complex
formed by the Gal4 BS oligonucleotide and Gal4 DBD tagged Gli3RD is
indicated on line 5. The shifted complex was competed out by
unlabelled Gal4 BS oligonucleotide (line 7). Scrambled sequence
oligonucleotide did not compete out the complex (line 6).
doi:10.1371/journal.pone.0076972.g003
Gli3RD Is Intrinsically Disordered
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Materials and Methods
Sequence analyses
Sequence analyses were carried out as described by Uversky
[31]. The mean net charge of a protein was determined as the
absolute value of the difference between the numbers of positively
and negatively charged residues divided by the total number of
residues. The mean hydrophobicity was defined as the sum of the
normalised Kyte-Doolittle hydrophobicities, divided by the total
number of residues. These values were then plotted together with
disorder-order boundary, which was defined as (charge) = 2.743
(hydrophobicity) – 1.109. Sequences were also analysed using
series neural network predictors as implemented in PONDR VL-
XT (pondr.com) [28]. For the secondary structure prediction the
Hierarchical Neural Network prediction method was used [29]
(http://npsa-devel.ibcp.fr/NPSA/npsa_hnn.html).
DNA constructs
For production of recombinant protein the cDNA for human
Gli3RD (residues 106 to 236) was cloned into pET11C (Novagen,
USA). An N-terminal 6xHis-tag was designed into the primer
followed immediately by the RD sequence. The cDNA for human
Ski (residues 88 to 291) was cloned into pMAL vector. For
expression of Gli3RD in mammalian cells, we used the pFA
Gli3RD construct described in [7] where the Gli3RD cDNA was in
frame with the DBD of yeast Gal4 (Stratagene, La Jolla, CA). We
used the pMN-Luc plasmid containing a thymidine kinase promoter
with five tandem repeats of the yeast GAL4 binding sites that
control expression of the firefly luciferase gene as a Gal4 reporter
construct. The Gli3RD mutants were cloned in pFA vector
produced as described in QuikChange protocol (Stratagene).
Protein expression and purification
Expression of recombinant 6xHis-Gli3RD (Gli3RD) was carried
out in E. coli strain BL21. For 15N labelling the cells were grown in
minimal medium supplemented with glucose and 15NH4Cl in a
volume of 1 litre in fermentor and expressed for 5 hours by
induction with 0.5 mM IPTG at 30uC. Cells were harvested by
centrifugation. The pellet was resuspended in 40 ml of ice-cold
lysis buffer (100 mM NaH2PO4; 10 mM Tris?Cl; 8 M urea pH 8).
The cells were lysed by 3 cycles of freeze-and-thaw in liquid
nitrogen and cold-water bath. Then, the sample was subjected to
sonication with 5 s ON and 15 s OFF cycles for 90 s on ice water
bath. The cell lysate was cleared by centrifugation for 15 min,
4uC, 10 000 rpm. The supernatant was transferred to a new vial
and 2 ml of lysis buffer-washed Ni-resin (Qiagen, Hilden,
Germany) was added. The binding was carried out at 4uC for
20 min. The Gli3RD bound resins were collected by centrifuga-
tion for 10 min, 4uC, 6 000 rpm. The resin was washed 2 times
with 10 ml of washing buffer (50 mM NaH2PO4; 300 mM NaCl;
20 mM imidazole; pH 8) and collected by centrifugation for
10 min, 4uC, 6 000 rpm. The Gli3RD was eluted with 2 ml of
elution buffer (50 mM NaH2PO4; 300 mM NaCl; pH 4,5) and
then further purified with C18 reversed-phase chromatography
(described in Methods S1) and lyophilized until used. The
reversed-phase chromatograms are shown in Figure S1 and
Figure S3, the mass spectrum is shown in Figure S2. The final
yield of purified Gli3RD was 4 mg per 1 g of biomass, the SDS-
PAGE shown in Figure S4.
The soluble Ski was expressed in BL21 cells that have been
transformed with pMal plasmid (New England Biolabs, Ipswich,
MA). Ski was tagged with MBP and GFP to facilitate expression
and purification process. The expression of the recombinant
protein was indused with 0.5 mM IPTG for 16 h at 20uC in LB
medium. The centrifuged cells were resuspended in 40 ml of ice-
cold column buffer (20 mM Tris-HCl; 200 mM NaCl; 1 mM
EDTA pH 7.4). Cells were lysed with lysozyme 1 mg/ml for
30 min on ice/water bath, followed by freeze-and-thaw and
sonication as for Gli3RD. The cleared lysate was incubated with
1 ml of column buffer washed amylose resin (New England
Figure 4. The luciferase reporter activity together with different Gli3RD variants. (A) All Gli3RD constructs were expressed as Gal4 DBD
fusions in HEK293 cells and their repressor activity is compared to that of Gal4 DBD alone (mock). The activity of Gla4-Gli3RD is shown as WT. The
analyses were performed three to five times and error bars show standard deviations. Statistically significant were WT vs MOCK, WT vs H141A and WT
vs H157N, p,0,001, One-Way ANOVA with Dunnett’s Multiple Comparisons Test. (B) The Agadir prediction of helical behaviour for Gli3RD variants.
doi:10.1371/journal.pone.0076972.g004
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Biolabs). The binding was carried out at 4uC for 20 min. Ski-
bound resin was washed 2 times with 10 ml of column buffer and
eluted with 1 ml column buffer containing 10 mM maltose. The
eluate was kept at 4uC until further use and concentrated to
0.05 mM on Amicon Ultra-0.5 mL Centrifugal Filters (Millipore,
Billerica, MA, USA).
Immunoprecipitation
To test the association of Gli3RD protein and Ski protein we
immunoprecipitated one protein and detected whether the other
one was co-precipitated. Both proteins were over-expressed as
tagged proteins in 293HEK cells. The cells were transfected in
15 cm culture dishes. For transfection the DNA/PEI complex was
prepared as follows: 30 mg of Gli3RD or Ski encoding DNA was
mixed with 60 mg of PEI per plate in 500 ml of DMEM. After
10 min of incubation 9 ml of DMEM was added to the DNA/PEI
mixture and then applied to the culture dish. After 2 h the
medium was exchanged for DMEM supplemented with 10% FCS.
On the following day, the medium was changed again and after an
additional 24 h cells were lysed in 1 ml PBS with 1% Triton X-
100 (Sigma–Aldrich). The lysate was cleared by centrifugation at
13 000 rpm for 15 min at 4uC.
For immunoprecipitation of Gli3RD, 5 ml of anti-Gal4 poly-
clonal antibodies (Santa Cruz Biotechnology, Santa Cruz, CA,
USA) or for Ski, 5 ml of anti-GluGlu polyclonal antibodies
(Abcam, Cambridge,UK) were incubated with 30 ml Protein G
agarose (Amersham Biosciences, Bucks, UK) for 1 h at 4uC. After
that 1 ml of cell lysate was added and immunoprecipitation was
performed at 4uC overnight and analyzed by Western blot using
Gal4 monoclonal antibodies (Santa Cruz Biotechnology), to detect
Gli3RD or GluGlu monoclonal antibodies (Abcam, Cambrid-
ge,UK) to detect Ski.
Electrophoretic Mobility Shift Assay
To test the association of Gli3RD with DNA we incubated cell
lysate of HEK293 cells expressing Gli3RD and oligonucleotides
containing either Gal4 binding site (Gal4BS) or scrambled
sequence. The transfected cells were washed with PBS and cells
were collected from the 10 mm plate in 0.5 ml of whole cell
extraction buffer (20 mM Hepes-KOH, pH 7.9, 400 mM KCl,
1 mM EDTA, 10% (v/v) Glycerol, with freshly added 10 mM
DTT, 1 mM PMSF and 16Complete protease inhibitor cocktail,
Roche Diagnostics GmbH, Mannheim, Germany). The cells were
lysed in 3 cycles of freezing and thawing in liquid nitrogen and ice
bath. The lysate was cleared by 15 min centrifugation, 4uC, 14
000 rpm. The supernatant was aliquoted and kept in 280uC until
needed. The untransfected cells used as a negative control were
treated likewise.
The two strands of Gal4BS or scrambled oligonucleotides were
annealed and labelled with Klenow fragment of DNA polymerase
(Bioron, HeidelbergGermany). The labelling reaction was set as
follows: 10.5 ml H2O, 1.5 ml Reaction buffer (Bioron), 1 ml
oligonucleotides (from 4 mM annealed stock), 1 ml [a-32P] dCTP
(GE Healthcare, UK) and 1 ml Klenow. The reaction was
incubated for 30 min at 37uC. Then, 2 ml dCTP (10 mM stock)
was added and incubated for an additional 10 min at 37uC. For
purification of labelled oligonucleotides from unincorporated label
80 ml Tris-EDTA (10 mM Tris-HCl, pH 7.5; 1 mM EDTA) was
added to the probe and the total of 100 ml was run over a NAP-5
Sephadex G25 column (GE Healthcare, London, UK). The
column was washed with 400 mL Tris-EDTA. Additional 0.5 ml of
Tris-EDTA was added to elute the labelled oligonucleotides.
Band shift binding reactions were assembled by adding 10 ml
binding buffer (2x stock: 100 mM HEPES, pH 7.4; 100 mM KCl;
10 mM MgCl2; 20 mM ZnSO4; 2 mM DTT; 40% glycerol) [2],
1 ml cell lysate, 2 ml labelled Gal4 BS or scrambled oligonucleo-
tides and H2O to the total volume of 20 mL. While using Gal4BS
oligonucleotides 1 ml of poly-(dI-dC) (1 mg/mL, Sigma) was added
to eliminate unspecific binding to DNA. To test the specificity of
the binding complex 2 ml (from 4 mM stock) of unlabelled Gal4BS
oligonucleotides or unlabelled scrambled oligonucleotides were
added, and preincubated for 15 min at room temperature. Then
all the band shift binding reactions were incubated at room
temperature for 15 min and loaded on 5% nondenaturing
polyacrylamide gel in 1x TBE buffer. Before loading, the gel
was pre run for 1.5 h, 100 V at 4uC. After loading, the gel was run
for 2 h, 200 V at 4uC. and then dried on a Whatman paper
(Whatman Ltd, Maidstone, UK) and visualised on a Roentgen
film (Agfa HealthCare,Mortsel, Belgium). The gel and the film
were assembled in cassette (Kodak, New York, NY USA) and
exposed at 270uC for 24 hours.
Cell culture
HEK293 cells were grown and transfected as previously
described [7]. The cells were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% Fetal Calf
Serum FCS (PAA Laboratories, Pasching, Austria), streptomycin
and penicillin (100 units/ml; Invitrogen, Carlsbad, CA). Cells
were grown at 37uC and 5.0% CO2 in cell culture incubator. One
day before transfection the cells were splitted into the required
plates.
Luciferase assays
A DNA plasmid encoding luciferase gene with upstream Gal4
binding sites was used as a reporter. The effector plasmid
contained Gli3RD DNA, cloned in frame with Gal4 DNA
binding domain (DBD). The plasmids were transfected into
mammalian cells. The effector plasmid expressed a fusion protein
consisting of Gal4 DBD and Gli3RD. This fusion protein bind to
the Gla4 binding sites of the reporter plasmid through the Gal4
DBD and alters the expression of the liciferase gene. We compare
the activity of the reporter in the presence and absence of Gla4-
Gl3RD. Transfections for luciferase assays were performed in 24-
well plates. The Gli3RD WT and mutated constructs were
transfected in HEK293 cells. For transfection efficiency control the
b-gal construct was used. The amount of reporter plasmid (pMN-
Luc) and the effector plasmids (pFA Gal4 fusions expressing RD or
RD mutants) used were 300 ng and 100 ng per well, respectivly.
For normalization we used 50 ng of pCMV-b-gal. As a
transfecting agent we used Polyethyleneimine (PEI; Sigma-
Aldrich, St. Louise, USA) 1 mg per well. DNA and PEI were
mixed in 50 ml of DMEM. An additional 150 ml of DMEM was
added to the DNA/PEI mixture and then applied to the cells.
After 2 hours of incubation the medium was exchanged by
DMEM with 10% FCS. On the following day the medium was
changed again. Cells were harvested after an additional 24 hours
of incubation. Firefly luciferase and b-gal assays were performed in
Ascent FL fluoroscan with the Luciferase Assay Kit (BioTherma,
Dalaro¨, Sweden) and Galacto-Light Plus System (Applied Biosys-
tems, Foster City, CA). One-Way ANOVA with Dunnett’s
Muliple Comparisons Test (GraphPad) was used to determine
the statistical significance of differential findings between exper-
imental groups.
CD and NMR analyses of Gli3RD
The in-cell NMR measurements were carried out with cells
prepared as described by Serber [37]. The recombinant E.coli was
grown to OD600,1 in LB medium, then the cells were pelleted by
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centrifugation (3750 g for 3 min) and transferred to the expression
medium (M9) containing 15NH4Cl and glycerol. After induction
with 0.5 mM IPTG for 7 h at 30uC the cells were pelleted (20 min
at 800 g), transferred to PBS buffer containing 10% D2O and kept
on ice until the NMR measurements.
For NMR measurements the lyophilised Gli3RD was resus-
pended in 50 mM phosphate buffer pH 5.8 or PBS containing
10% D2O, to a final concentration of 0.13 mM. NMR spectra
were acquired using a Bruker Avance III spectrometer operating
at 800 MHz proton resonance frequency. 1H-15N HSQC spectra
were recorded using 79 ms acquisition time in the 1H dimension
and 51 ms acquisition time in the 15N dimension. 4 repetitions
were averaged for 256 increments in the indirect dimension.
Spectral widths were 8000 Hz for 1H and 2500 Hz for the 15N
dimension. All NMR data processing was performed using
TopSpin software (Bruker, Germany).
The CD measurements of DNA binding to Gli3RD were
assembled in binding buffer (20 mM HEPES pH 7.9, 80 mM KCl
and 4 mM MgCl2) by adding equimolar concentrations of
lyophilised protein and 21 bp scrambled sequence synthetic
oligonucleotides or a plasmid DNA to exclude DNA size
requirements. The concentration of the protein was measured
spectrophotometrically on ND-1000 (NanoDrop Technologies,
Wilmington, DE, USA). CD spectra were obtained with a Jasco J-
720 spectropolarimeter (Jasco, Easton, MO) and the temperature
was controlled with a PTC-343 temperature controller. A quartz
cell with 2 mm optical path was used. The spectral range was 190
– 250 nm with a resolution of 0.2 nm and a bandwidth of 2 nm. A
scan speed of 50 nm/min with 2 s response time was employed.
The buffer-background spectrum was subtracted.
Supporting Information
Figure S1 The UV chromatogram of the sample Gli3RD,
280 nm. The peak RT 16,52 min was identified as protein with
MW 15570.9 Da on the basis of the ESI-MS spectrum
deconvulated with the MagTrans software.
(TIF)
Figure S2 The ESI-MS spectrum of Gli3RD.
(PDF)
Figure S3 Overlaid chromatograms of the sample
Gli3RD. Black - UV 280 nm, red - TIC m/z 300 – 2000 Da.
(TIF)
Figure S4 The SDS-PAGE of Gli3RD. The gel was made
to 12% acrylamide, bis-acrylamide 29:1.
(JPG)
Methods S1 HPLC purification.
(DOC)
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